[1]
|
[1] Song, J., Yang, B., Jia, X., et al. (2018) Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental? Frontiers in Endocrinology, 9, Article 724. https://doi.org/10.3389/fendo.2018.00724
|
[2]
|
Hong, J.Y. and Lin, H. (2021) Sirtuin Modulators in Cellular and Animal Models of Human Diseases. Frontiers in Pharmacology, 12, Article 735044. https://doi.org/10.3389/fphar.2021.735044
|
[3]
|
Ungurianu, A., Zanfirescu, A. and Margina, D. (2022) Regulation of Gene Expression through Food-Curcumin as a Sirtuin Activity Modulator. Plants, 11, Article No. 1741. https://doi.org/10.3390/plants11131741
|
[4]
|
Colloca, A., Balestrieri, A., Anastasio, C., Balestrieri, M.L. and D’Onofrio, N. (2022) Mitochondrial Sirtuins in Chronic Degenerative Diseases: New Metabolic Targets in Colorectal Cancer. International Journal of Molecular Sciences, 23, Article No. 3212. https://doi.org/10.3390/ijms23063212
|
[5]
|
Ezhilarasan, D., Lakshmi, T., Subha, M., et al. (2022) The Ambiguous Role of Sirtuins in Head and Neck Squamous Cell Carcinoma. Oral Diseases, 28, 559-567. https://doi.org/10.1111/odi.13798
|
[6]
|
Pugliese, N., Plaz Torres, M.C., Petta, S., et al. (2022) Is There an ‘ideal’ Diet for Patients with NAFLD? European Journal of Clinical Investigation, 52, e13659. https://doi.org/10.1111/eci.13659
|
[7]
|
Roshdy, E., Mustafa, M., Shaltout, A.E., et al. (2021) Selective SIRT2 In-hibitors as Promising Anticancer Therapeutics: An Update from 2016 to 2020. European Journal of Medicinal Chemis-try, 224, Article ID: 113709.
https://doi.org/10.1016/j.ejmech.2021.113709
|
[8]
|
Elkhwanky, M.-S. and Hakkola, J. (2018) Extranuclear Sirtuins and Metabolic Stress. Antioxidants & Redox Signaling, 28, 662-676. https://doi.org/10.1089/ars.2017.7270
|
[9]
|
Zheng, M., Hu, C., Wu, M. and Chin, Y.E. (2021) Emerging Role of SIRT2 in Non-Small Cell Lung Cancer. Oncology Letters, 22, Article No. 731. https://doi.org/10.3892/ol.2021.12992
|
[10]
|
Taneja, A., Ravi, V., Hong, J.Y., Lin, H. and Sundaresan, N.R. (2021) Emerging Roles of Sirtuin 2 in Cardiovascular Diseases. The FASEB Journal, 35, e21841. https://doi.org/10.1096/fj.202100490R
|
[11]
|
Pouwels, S., Sakran, N., Graham, Y., et al. (2022) Non-Alcoholic Fatty Liver Disease (NAFLD): A Review of Pathophysiology, Clinical Management and Effects of Weight Loss. BMC Endocrine Disorders, 22, Article No. 63.
https://doi.org/10.1186/s12902-022-00980-1
|
[12]
|
Scorletti, E. and Carr, R.M. (2022) A New Perspective on NAFLD: Focusing on Lipid Droplets. Journal of Hepatology, 76, 934-945. https://doi.org/10.1016/j.jhep.2021.11.009
|
[13]
|
Shah, P.A., Patil, R. and Harrison, S.A. (2023) NAFLD-Related Hepatocellular Carcinoma: The Growing Challenge. Hepatology, 77, 323-338. https://doi.org/10.1002/hep.32542
|
[14]
|
Chen, B., Tang, W.H.W., Rodriguez, M., et al. (2022) NAFLD in Cardio-vascular Diseases: A Contributor or Comorbidity? Seminars in Liver Disease, 42, 465-474. https://doi.org/10.1055/s-0042-1757712
|
[15]
|
Li, W., Liu, J., Cai, J., et al. (2022) NAFLD as a Continuous Driver in the Whole Spectrum of Vascular Disease. Journal of Molecular and Cellular Cardiology, 163, 118-132. https://doi.org/10.1016/j.yjmcc.2021.10.007
|
[16]
|
Wong, V.W.S., Zelber-Sagi, S., Cusi, K., et al. (2022) Manage-ment of NAFLD in Primary Care Settings. Liver International, 42, 2377-2389. https://doi.org/10.1111/liv.15404
|
[17]
|
Yang, M. and Wei, L. (2022) Impact of NAFLD on the Outcome of Patients with Chronic Hepatitis B in Asia. Liver International, 42, 1981-1990. https://doi.org/10.1111/liv.15252
|
[18]
|
Nakatsuka, T., Tateishi, R. and Koike, K. (2022) Changing Clinical Man-agement of NAFLD in Asia. Liver International, 42, 1955-1968. https://doi.org/10.1111/liv.15046
|
[19]
|
Chauhan, M., Singh, K. and Thuluvath, P.J. (2022) Bariatric Surgery in NAFLD. Digestive Diseases and Sciences, 67, 408-422. https://doi.org/10.1007/s10620-021-07317-3
|
[20]
|
Li, D.-J., Sun, S.-J., Fu, J.-T., et al. (2021) NAD+-Boosting Therapy Alleviates Nonalcoholic Fatty Liver Disease via Stimulating a Novel Exerkine Fndc5/Irisin. Theranostics, 11, 4381-4402. https://doi.org/10.7150/thno.53652
|
[21]
|
Zhang, B., Xu, D., She, L., et al. (2018) Silybin Inhibits NLRP3 Inflammasome Assembly through the NAD+/SIRT2 Pathway in Mice with Nonalcoholic Fatty Liver Disease. The FASEB Journal, 32, 757-767.
https://doi.org/10.1096/fj.201700602R
|
[22]
|
Leal, H., Cardoso, J., Valerio, P., et al. (2022) SIRT2 Deficiency Ex-acerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway. International Journal of Molecular Sciences, 23, Article No. 6790.
https://doi.org/10.3390/ijms23126790
|
[23]
|
Ren, H., Hu, F., Wang, D., et al. (2021) Sirtuin 2 Prevents Liver Stea-tosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4alpha. Hepatology, 74, 723-740. https://doi.org/10.1002/hep.31773
|
[24]
|
Zhou, Z., Qi, J., Kim, J.-W., et al. (2020) AK-1, a Sirt2 Inhibitor, Alleviates Carbon Tetrachloride-Induced Hepatotoxicity in Vivo and in Vitro. Toxicology Mechanisms and Methods, 30, 324-335.
https://doi.org/10.1080/15376516.2020.1729915
|
[25]
|
Wu, D.-Q., Ding, Q.-Y., Tao, N.-N., et al. (2022) SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters. Frontiers in Microbiology, 13, Article 836446. https://doi.org/10.3389/fmicb.2022.836446
|
[26]
|
Cheng, S.-T., Ren, J.-H., Cai, X.-F., Jiang, H. and Chen, J. (2018) HBx-Elevated SIRT2 Promotes HBV Replication and Hepatocarcinogenesis. Biochemical and Biophysical Research Communications, 496, 904-910.
https://doi.org/10.1016/j.bbrc.2018.01.127
|
[27]
|
Wang, B., Ye, Y., Yang, X., et al. (2020) SIRT2-Dependent IDH1 Deacetylation Inhibits Colorectal Cancer and Liver Metastases. EMBO Reports, 21, e48183. https://doi.org/10.15252/embr.201948183
|
[28]
|
Zhang, Y., Long, X., Ruan, X., et al. (2021) SIRT2-Mediated Deacetylation and Deubiquitination of C/EBPβ Prevents Ethanol-Induced Liver Injury. Cell Discovery, 7, Article No. 93. https://doi.org/10.1038/s41421-021-00326-6
|
[29]
|
Shao, Y., Wang, X., Zhou, Y., et al. (2021) Pterostilbene Atten-uates RIPK3-Dependent Hepatocyte Necroptosis in Alcoholic Liver Disease via SIRT2-Mediated NFATc4 Deacetyla-tion. Toxicology, 461, Article ID: 152923.
https://doi.org/10.1016/j.tox.2021.152923
|
[30]
|
Chen, G., Huang, P. and Hu, C. (2020) The Role of SIRT2 in Can-cer: A Novel Therapeutic Target. International Journal of Cancer, 147, 3297-3304. https://doi.org/10.1002/ijc.33118
|
[31]
|
Chen, X., Lu, W. and Wu, D. (2021) Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders. Frontiers in Neuroscience, 15, Article 614107. https://doi.org/10.3389/fnins.2021.614107
|
[32]
|
Manjula, R., Anuja, K. and Alcain, F.J. (2020) SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases. Frontiers in Pharmacology, 11, Article 585821. https://doi.org/10.3389/fphar.2020.585821
|
[33]
|
Zhang, Y., Anoopkumar-Dukie, S. and Davey, A.K. (2021) SIRT1 and SIRT2 Modulators: Potential Anti-Inflamma- tory Treatment for Depression? Biomolecules, 11, Article No. 353. https://doi.org/10.3390/biom11030353
|
[34]
|
Kaitsuka, T., Matsushita, M. and Matsushita, N. (2021) Regulation of Hypoxic Signaling and Oxidative Stress via the MicroRNA-SIRT2 Axis and Its Relationship with Aging-Related Dis-eases. Cells, 10, Article No. 3316.
https://doi.org/10.3390/cells10123316
|
[35]
|
Fan, Z. and Bin, L. (2022) Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders? Frontiers in Cellular Neuroscience, 16, Article 915587. https://doi.org/10.3389/fncel.2022.915587
|
[36]
|
Wu, B., You, S., Qian, H., et al. (2021) The Role of SIRT2 in Vascular-Related and Heart-Related Diseases: A Review. Journal of Cellular and Molecular Medicine, 25, 6470-6478. https://doi.org/10.1111/jcmm.16618
|
[37]
|
Gu, W., Cheng, Y., Wang, S., Sun, T. and Li, Z. (2021) PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2. Cardiovascular Toxicology, 21, 451-461.
https://doi.org/10.1007/s12012-021-09639-0
|
[38]
|
Zheng, M., Du, X., Zhao, L., et al. (2021) Elevated Plasma Sirtuin2 Level Predicts Heart Failure after Acute Myocardial Infarction. Journal of Thoracic Disease, 13, 50-59. https://doi.org/10.21037/jtd-20-2234
|
[39]
|
Yang, X., Chang, H.-C., Tatekoshi, Y., et al. (2023) SIRT2 Inhibition Protects against Cardiac Hypertrophy and Heart Failure. BioRxiv. https://doi.org/10.1101/2023.01.25.525524
|
[40]
|
Perrini, S., Porro, S., Nigro, P., et al. (2020) Reduced SIRT1 and SIRT2 Expression Promotes Adipogenesis of Human Visceral Adipose Stem Cells and Associates with Accumulation of Visceral Fat in Human Obesity. International Journal of Obesity, 44, 307-319. https://doi.org/10.1038/s41366-019-0436-7
|
[41]
|
Arab Sadeghabadi, Z., Ziamajidi, N., Abbasalipourkabir, R., et al. (2018) Garlic (Allium sativum) Increases SIRT1 and SIRT2 Gene Expressions in the Kidney and Liver Tissues of STZ- and STZ+Niacinamide-Induced Diabetic Rats. Journal of Basic and Clinical Physiology and Pharmacology, 29, 463-467. https://doi.org/10.1515/jbcpp-2017-0079
|